Joosten, R
(Source: Segments Covered in the Report By Treatment Type Pharmacological Therapy Prokinetic Agents (Metoclopramide, Domperidone, Cisapride, Others) Antiemetic Agents (Ondansetron, Prochlorperazine, Promethazine, Others) Gastric Motility Modulators (Erythromycin, Ghrelin Agonists, Others) Others (Antidepressants, Analgesics for symptom management) Device-based Therapy Gastric Electrical Stimulation (GES) Systems Endoscopic Procedures (Per-oral Endoscopic Pyloromyotomy POP, Botulinum Toxin Injections) Others (Magnetic bead-assisted techniques, emerging neurostimulation devices) Surgical Treatment Partial Gastrectomy Pyloroplasty Others (Jejunostomy feeding tubes, Combination approaches) Nutritional and Dietary Management Oral Nutrition Supplements Enteral Nutrition (Jejunal feeding) Parenteral Nutrition Others (Dietary counselling, liquid diets) By Disease Type Diabetic Gastroparesis Idiopathic Gastroparesis Post-Surgical Gastroparesis Others (Drug-induced, Neurological disorders, Autoimmune-related) By End User Hospitals Specialty Clinics and Gastroenterology Centers Ambulatory Surgical Centers (ASCs) Home Care Settings Others (Rehabilitation centers, Long-term care facilities) By Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies Others (Direct procurement, Specialty distributors) By Region North America Europe Asia-Pacific Latin America Middle East and Africa For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at [email protected] Frequently Asked Questions Answer : The gastroparesis treatment market size is expected to increase from USD 6.63 billion in 2024 to USD 10.45 billion by 2034
Aesthetic Medicine Skin Clinic in London Find a treatment suitable for you Type in your concern IV Drip Therapy London
34% on placebo at 72 weeks
